0001179110-13-012261.txt : 20130729 0001179110-13-012261.hdr.sgml : 20130729 20130729194602 ACCESSION NUMBER: 0001179110-13-012261 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130726 FILED AS OF DATE: 20130729 DATE AS OF CHANGE: 20130729 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ONYX PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001012140 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943154463 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 249 E. GRAND AVE. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-266-0000 MAIL ADDRESS: STREET 1: 249 E. GRAND AVE. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GRILLO LOPEZ ANTONIO J CENTRAL INDEX KEY: 0001235942 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-28298 FILM NUMBER: 13993818 4 1 edgar.xml FORM 4 - X0306 4 2013-07-26 0 0001012140 ONYX PHARMACEUTICALS INC ONXX 0001235942 GRILLO LOPEZ ANTONIO J C/O ONYX PHARMACEUTICALS, INC. 249 E. GRAND AVE. SOUTH SAN FRANCISCO CA 94080 1 0 0 0 Common Stock 2013-07-26 4 M 0 2000 76.79 A 5600 D Common Stock 2013-07-26 4 S 0 2000 130.50 D 3600 D Stock Option (Right to Buy) 76.79 2013-07-26 4 M 0 2000 0.00 D 2013-07-25 2022-07-24 Common Stock 2000 0 D Shares sold pursuant to 10b5-1 plan. /s/ Warren DeSouza, Attorney-In-Fact 2013-07-29